Carregant...
A Histone Deacetylase-Dependent Screen in Yeast
Histone deacetylase (HDAC) proteins are promising targets for cancer treatment, as shown by the recent FDA approval of the HDAC inhibitor suberoylanilide hydroxamic acid (SAHA, Vorinostat,) for the treatment of cutaneous T-cell lymphoma. To identify additional potent inhibitors and characterize HDAC...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2010
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3033752/ https://ncbi.nlm.nih.gov/pubmed/20863708 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bmc.2010.08.045 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|